返回 Agenda
How to De-Risk Alliances for Success
Session Chair(s)
Candice M Hughes, PHD, MBA
CEO/Founder
Hughes BioPharma Advisers LLC, United States
A significant number of partnerships fail. By going beyond standard practices to de-risk for success pre- and post-partnering, firms can avoid reduced revenue, elevated costs and brand damage due to failed alliances and partnerships. This session will include how to make a go or no go decision plus engagement on an ongoing basis, including periodic checks on milestones and soft targets such as engagement level, communication effectiveness, and others.
Learning Objective : State at least three common causes of partnership failure; Explain hard and soft (such as cultural) due diligence; Describe at least three activities or strategies a sponsor or vendor may use to de-risk a partnership/alliance.
Speaker(s)
De-Risking Alliances, The Sponsor Perspective: Transforming Expectations and Implementing Innovations for Joint Oversight
Jessica Dero, PMP
Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Vendor Strategy
The Vendor Perspective on De-Risking Partnerships for Shared Success
Candice M Hughes, PHD, MBA
Hughes BioPharma Advisers LLC, United States
CEO/Founder
Sponsor Perspective
Alison Schecter, MD, FACC
Sanofi, United States
Global Project Head, Rare Disease